◆BLACKSPECTER AI Chat öffnen →

BlackSpecter›Aktien›A

A (A)

Kennzahlen

Marktkapitalisierung

n/a

KGV (TTM)

n/a

Umsatz (TTM)

n/a

EBITDA

n/a

Dividendenrendite

n/a

52W Hoch

n/a

52W Tief

n/a

Beta

n/a

EPS (TTM)

n/a

Forward KGV

n/a

PEG Ratio

n/a

Short-Quote

n/a

Analysten-Ratings

Keine Analysten-Daten verfügbar

Earnings

Keine Earnings-Daten verfügbar

Aktuelle News

MT Newswires·vor 23 Std.

Agilent Wins FDA Approval for PD-L1 Test to Guide Bristol Myers' Opdivo Use in GI Cancers

Business Wire·vor 1 Tagen

Agilent Receives FDA Approval for PD-L1 IHC 28-8 pharmDx in Esophageal Squamous Cell Carcinoma (ESCC), Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinoma

Trefis·vor 1 Tagen

Alamar Hits A High Note On Alzheimer's Buzz

StockStory·vor 1 Tagen

Agilent (A): Buy, Sell, or Hold Post Q1 Earnings?

MT Newswires·vor 1 Tagen

Baird Adjusts Agilent Technologies Price Target to $160 From $158, Maintains Outperform Rating

Zacks·vor 5 Tagen

Agilent Strengthens Biopharma Growth Prospects With AI Expansion

Frag BlackSpecter AI über A

Earnings-Analyse, Bewertungs-Check, Peer-Vergleich — in Sekunden.

Ist A kaufenswert?A Earnings Analyse A Bewertung

AI Chat öffnen →